SCHEMBL29614975

SCHEMBL29614975

C[C@@H]1CN(CCCCCCCCNC=O)C[C@H](C)O1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.59
EBP Q15125 1/20 0.59
KDM4E B2RXH2 6/20 0.42
ALDH1A1 P00352 5/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
HTT P42858 2/20 0.42
ADH1B P00325 2/20 0.41
ADH1C P00326 2/20 0.41
ADH1A P07327 2/20 0.41
ADH7 P40394 2/20 0.41
EPHX1 P07099 1/20 0.41
ADH4 P08319 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
LMNA P02545 1/20 0.39
DRD2 P14416 1/20 0.38
HTR2A P28223 1/20 0.38
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2334083 0.78 EBP (0.56) SIGMAR1EBPKDM4EALDH1A1KMT2A
SCHEMBL2334088 0.78 EBP (0.56) SIGMAR1EBPKDM4EALDH1A1KMT2A
SCHEMBL4021409 0.76 SIGMAR1 (0.68) SIGMAR1EBPKDM4EALDH1A1KMT2A
SCHEMBL6808516 0.75 SIGMAR1 (0.41) SIGMAR1KDM4EALDH1A1KMT2AMEN1
SCHEMBL2560730 0.74 SIGMAR1 (0.50) SIGMAR1EBPKDM4EALDH1A1KMT2A
SCHEMBL23309796 0.74 SIGMAR1 (1.00) SIGMAR1EBPKDM4EALDH1A1HTT
Tridemorph SCHEMBL28670 0.74 SIGMAR1 (1.00) SIGMAR1EBPKDM4EALDH1A1HTT
SCHEMBL22222412 0.74 SIGMAR1 (1.00) SIGMAR1EBPKDM4EALDH1A1HTT
SCHEMBL20746950 0.74 SIGMAR1 (1.00) SIGMAR1EBPKDM4EALDH1A1HTT
SCHEMBL120500 0.74 SIGMAR1 (1.00) SIGMAR1EBPKDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250122545-A1 COMPOSITIONS FOR SACCHARIFICATION OF CELLULOSIC MATERIAL NOVOZYMES, INC. (US) 2025-04-17 US claimed
EP-2064323-B2 METHODS OF INCREASING THE CELLULOLYTIC ENHANCING ACTIVITY OF A POLYPEPTIDE NOVOZYMES INC (US) 2024-06-19 EP disclosed
EP-3681504-B1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN INC (US) 2023-08-23 EP disclosed
US-11573224-B2 Methods of detection using X-ray fluorescence ICAGEN, LLC (US) 2023-02-07 US disclosed
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
EP-3550016-B1 COMPOSITION FOR SACCHARIFICATION OF CELLULOSIC MATERIAL NOVOZYMES INC (US) 2022-05-04 EP disclosed